450 related articles for article (PubMed ID: 32170673)
1. The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders.
Wójtowicz S; Strosznajder AK; Jeżyna M; Strosznajder JB
Neurochem Res; 2020 May; 45(5):972-988. PubMed ID: 32170673
[TBL] [Abstract][Full Text] [Related]
2. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB
Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
4. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway.
Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
Int J Dev Neurosci; 2014 Nov; 38():223-31. PubMed ID: 25447788
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
Nierenberg AA; Ghaznavi SA; Sande Mathias I; Ellard KK; Janos JA; Sylvia LG
Biol Psychiatry; 2018 May; 83(9):761-769. PubMed ID: 29502862
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
Qi C; Zhu Y; Reddy JK
Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
Fidaleo M; Fanelli F; Ceru MP; Moreno S
Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
[TBL] [Abstract][Full Text] [Related]
11. Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Tufano M; Pinna G
Molecules; 2020 Feb; 25(5):. PubMed ID: 32120979
[TBL] [Abstract][Full Text] [Related]
12. ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling.
Khan SA; Sathyanarayan A; Mashek MT; Ong KT; Wollaston-Hayden EE; Mashek DG
Diabetes; 2015 Feb; 64(2):418-26. PubMed ID: 25614670
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.
Agarwal S; Yadav A; Chaturvedi RK
Biochem Biophys Res Commun; 2017 Feb; 483(4):1166-1177. PubMed ID: 27514452
[TBL] [Abstract][Full Text] [Related]
14. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.
Kumar M; Ashok SA; Datusalia AK; Khatik GL
Med Chem; 2024 May; ():. PubMed ID: 38726789
[TBL] [Abstract][Full Text] [Related]
15. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
16. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
Schoonjans K; Staels B; Auwerx J
Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
[TBL] [Abstract][Full Text] [Related]
18. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
[TBL] [Abstract][Full Text] [Related]
19. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model.
Katsouri L; Lim YM; Blondrath K; Eleftheriadou I; Lombardero L; Birch AM; Mirzaei N; Irvine EE; Mazarakis ND; Sastre M
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12292-12297. PubMed ID: 27791018
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
